Silva, S., Duarte, J., Simão, C. and Felizardo, M. 2025. Osimertinib: A Game-Changer in Stage IV EGFR-Driven Lung Cancer. Acta Médica Portuguesa. 38, 9 (Apr. 2025), 568–572. DOI:https://doi.org/10.20344/amp.22031.